Clinical Trial Update: Determination of Levels of Micafungin in Neonates Suffering From Systemic Candidiasis and/or Candida Meningitis [Phase 2]

View source ↗

Summary

Phase 2 trial completed to determine pharmacokinetic levels of micafungin in neonates with systemic candidiasis or Candida meningitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candida Meningitis
• Systemic Candidiasis

Drugs mentioned

• Micafungin (micafungin)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Candidiasis, Systemic, Candida Meningitis | Phase 2 | Status: COMPLETED